Technical Analysis for EKF - Ekf Diagnostics Holdings Plc

Grade Last Price % Change Price Change
grade C 29.75 -11.19% -3.75
EKF closed down 11.19 percent on Friday, February 28, 2020, on 1.6 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical EKF trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Multiple of Ten Bearish Other 0.00%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.
Medicine Clinical Medicine Diabetes Ekf Diagnostics Medical Tests

Is EKF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 37.962
52 Week Low 29.0
Average Volume 817,911
200-Day Moving Average 32.82
50-Day Moving Average 33.27
20-Day Moving Average 33.22
10-Day Moving Average 33.82
Average True Range 1.56
ADX 19.83
+DI 14.81
-DI 28.21
Chandelier Exit (Long, 3 ATRs ) 31.93
Chandelier Exit (Short, 3 ATRs ) 33.87
Upper Bollinger Band 35.82
Lower Bollinger Band 30.61
Percent B (%b) -0.17
BandWidth 15.69
MACD Line -0.02
MACD Signal Line 0.24
MACD Histogram -0.2514
Fundamentals Value
Market Cap 125.56 Million
Num Shares 4.22 Million
EPS 0.50
Price-to-Earnings (P/E) Ratio 59.50
Price-to-Sales 113.21
Price-to-Book 50.71
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.72
Resistance 3 (R3) 35.09 33.80 33.89
Resistance 2 (R2) 33.80 32.54 33.62 33.62
Resistance 1 (R1) 31.78 31.75 31.13 31.41 33.34
Pivot Point 30.49 30.49 30.17 30.30 30.49
Support 1 (S1) 28.46 29.22 27.82 28.09 26.16
Support 2 (S2) 27.17 28.44 26.99 25.88
Support 3 (S3) 25.15 27.17 25.61
Support 4 (S4) 24.78